Company / EPS (Diluted)
Whitehawk Therapeutics, Inc. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.36
FY2025
5-year range
-$12.41 / -$1.76
FY2021-FY2025
Trend
+3.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has increased for 3 consecutive years, from $-12.41 in FY2022 to $-2.36 in FY2025.
Based on SEC 10-K filings.
-2.36 in FY2025.
Improved from $-2.69 to $-2.36 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Whitehawk Therapeutics, Inc.'s eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 3.3% year-over-year.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.36 | +3.3% |
| FY2024 | -$2.44 | +9.3% |
| FY2023 | -$2.69 | +78.3% |
| FY2022 | -$12.41 | -605.1% |
| FY2021 | -$1.76 | -208.8% |
| FY2020 | -$0.57 | -83.9% |
| FY2019 | -$0.31 | +69.9% |
| FY2018 | -$1.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026